Literature DB >> 7944147

Role of heparan sulfate proteoglycans and the LDL receptor-related protein in remnant lipoprotein metabolism.

R W Mahley1, Z S Ji, W J Brecht, R D Miranda, D He.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7944147     DOI： 10.1111/j.1749-6632.1994.tb44300.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  9 in total

1.  Crystallization and preliminary X-ray diffraction analysis of apolipoprotein E-containing lipoprotein particles.

Authors:  Yvonne Newhouse; Clare Peters-Libeu; Karl H Weisgraber
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-10-20

2.  The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro.

Authors:  I V Fuki; K M Kuhn; I R Lomazov; V L Rothman; G P Tuszynski; R V Iozzo; T L Swenson; E A Fisher; K J Williams
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

Review 3.  The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis.

Authors:  Philip L S M Gordts; Jeffrey D Esko
Journal:  Matrix Biol       Date:  2018-05-24       Impact factor: 11.583

4.  An apolipoprotein E synthetic peptide targets to lipoproteins in plasma and mediates both cellular lipoprotein interactions in vitro and acute clearance of cholesterol-rich lipoproteins in vivo.

Authors:  I R Nikoulin; L K Curtiss
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

5.  CD36 and proteoglycan-mediated pathways for (n-3) fatty acid enriched triglyceride-rich particle blood clearance in mouse models in vivo and in peritoneal macrophages in vitro.

Authors:  Narumon Densupsoontorn; Yvon A Carpentier; Radjini Racine; Faith M Murray; Toru Seo; Rajasekhar Ramakrishnan; Richard J Deckelbaum
Journal:  J Nutr       Date:  2008-02       Impact factor: 4.798

6.  Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors.

Authors:  V S Kashyap; S Santamarina-Fojo; D R Brown; C L Parrott; D Applebaum-Bowden; S Meyn; G Talley; B Paigen; N Maeda; H B Brewer
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

7.  Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation.

Authors:  W A Boisvert; J Spangenberg; L K Curtiss
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

8.  Syndecan-1 mediates internalization of apoE-VLDL through a low density lipoprotein receptor-related protein (LRP)-independent, non-clathrin-mediated pathway.

Authors:  Larissa C Wilsie; Amanda M Gonzales; Robert A Orlando
Journal:  Lipids Health Dis       Date:  2006-08-31       Impact factor: 3.876

Review 9.  Lipoprotein receptors and lipid enzymes in hepatitis C virus entry and early steps of infection.

Authors:  Eve-Isabelle Pécheur
Journal:  Scientifica (Cairo)       Date:  2012-12-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.